GlaxoSmithKline Pharmaceuticals Limited — Others, 28-03-2025: Shareholders meeting

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting to seek shareholder approval for the re-appointment of Mr. Juby Chandy as Whole-time Director & CFO, alongside the appointments of Mr. Somasundaram Palamadairamaswamy and Mr. Anup Wadhawan as Independent Directors. The e-voting will commence on March 31, 2025, and run until April 29, 2025, with results announced by April 30, 2025. The appointments aim to strengthen governance and leverage the new directors’ extensive experience across finance and public administration, potentially enhancing the company’s strategic direction and operational framework. Investor sentiment may remain positive given the emphasis on strong leadership.